Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.
exosome
glioma
methylome
mutation
proteomics
Journal
Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
pubmed:
29
1
2021
medline:
5
8
2021
entrez:
28
1
2021
Statut:
ppublish
Résumé
Genome-wide DNA methylation profiling has recently been developed into a tool that allows tumor classification in central nervous system tumors. Extracellular vesicles (EVs) are released by tumor cells and contain high molecular weight DNA, rendering EVs a potential biomarker source to identify tumor subgroups, stratify patients and monitor therapy by liquid biopsy. We investigated whether the DNA in glioblastoma cell-derived EVs reflects genome-wide tumor methylation and mutational profiles and allows noninvasive tumor subtype classification. DNA was isolated from EVs secreted by glioblastoma cells as well as from matching cultured cells and tumors. EV-DNA was localized and quantified by direct stochastic optical reconstruction microscopy. Methylation and copy number profiling was performed using 850k arrays. Mutations were identified by targeted gene panel sequencing. Proteins were differentially quantified by mass spectrometric proteomics. Genome-wide methylation profiling of glioblastoma-derived EVs correctly identified the methylation class of the parental cells and original tumors, including the MGMT promoter methylation status. Tumor-specific mutations and copy number variations (CNV) were detected in EV-DNA with high accuracy. Different EV isolation techniques did not affect the methylation profiling and CNV results. DNA was present inside EVs and on the EV surface. Proteome analysis did not allow specific tumor identification or classification but identified tumor-associated proteins that could potentially be useful for enriching tumor-derived circulating EVs from biofluids. This study provides proof of principle that EV-DNA reflects the genome-wide methylation, CNV, and mutational status of glioblastoma cells and enables their molecular classification.
Sections du résumé
BACKGROUND
Genome-wide DNA methylation profiling has recently been developed into a tool that allows tumor classification in central nervous system tumors. Extracellular vesicles (EVs) are released by tumor cells and contain high molecular weight DNA, rendering EVs a potential biomarker source to identify tumor subgroups, stratify patients and monitor therapy by liquid biopsy. We investigated whether the DNA in glioblastoma cell-derived EVs reflects genome-wide tumor methylation and mutational profiles and allows noninvasive tumor subtype classification.
METHODS
DNA was isolated from EVs secreted by glioblastoma cells as well as from matching cultured cells and tumors. EV-DNA was localized and quantified by direct stochastic optical reconstruction microscopy. Methylation and copy number profiling was performed using 850k arrays. Mutations were identified by targeted gene panel sequencing. Proteins were differentially quantified by mass spectrometric proteomics.
RESULTS
Genome-wide methylation profiling of glioblastoma-derived EVs correctly identified the methylation class of the parental cells and original tumors, including the MGMT promoter methylation status. Tumor-specific mutations and copy number variations (CNV) were detected in EV-DNA with high accuracy. Different EV isolation techniques did not affect the methylation profiling and CNV results. DNA was present inside EVs and on the EV surface. Proteome analysis did not allow specific tumor identification or classification but identified tumor-associated proteins that could potentially be useful for enriching tumor-derived circulating EVs from biofluids.
CONCLUSIONS
This study provides proof of principle that EV-DNA reflects the genome-wide methylation, CNV, and mutational status of glioblastoma cells and enables their molecular classification.
Identifiants
pubmed: 33508126
pii: 6122789
doi: 10.1093/neuonc/noab012
pmc: PMC8673443
doi:
Substances chimiques
DNA
9007-49-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1087-1099Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Int J Mol Sci. 2020 Mar 12;21(6):
pubmed: 32178271
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Neuro Oncol. 2014 Apr;16(4):520-7
pubmed: 24435880
NPJ Precis Oncol. 2018 Dec 12;2:28
pubmed: 30564636
Clin Cancer Res. 2012 Apr 1;18(7):1901-13
pubmed: 22316604
ACS Nano. 2018 Jan 23;12(1):494-503
pubmed: 29286635
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Acta Neuropathol. 2018 Aug;136(2):181-210
pubmed: 29967940
Oncogene. 2008 May 1;27(20):2897-909
pubmed: 18037961
Sci Transl Med. 2020 Jun 17;12(548):
pubmed: 32554709
J Extracell Vesicles. 2018 Aug 07;7(1):1505403
pubmed: 30108686
Nat Med. 2020 Jul;26(7):1044-1047
pubmed: 32572265
Nat Commun. 2017 May 16;8:15287
pubmed: 28508895
J Extracell Vesicles. 2019 Jan 09;8(1):1555419
pubmed: 30651939
Cell Res. 2014 Jun;24(6):766-9
pubmed: 24710597
J Biol Chem. 2014 Feb 14;289(7):3869-75
pubmed: 24398677
Oncotarget. 2017 Jan 3;8(1):1416-1428
pubmed: 27902458
J Extracell Vesicles. 2019 Mar 21;8(1):1588555
pubmed: 30949309
Clin Cancer Res. 2019 May 15;25(10):3115-3127
pubmed: 30679164
FASEB J. 2009 May;23(5):1541-57
pubmed: 19109410
Mol Ther Nucleic Acids. 2013 Jul 23;2:e109
pubmed: 23881452
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Commun Biol. 2019 Aug 19;2:315
pubmed: 31453379
Clin Cancer Res. 2018 Jun 15;24(12):2951-2962
pubmed: 29563135
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
J Mol Diagn. 2016 May;18(3):350-361
pubmed: 26927331
J Extracell Vesicles. 2019 Nov 27;9(1):1689784
pubmed: 31839905
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9704-9
pubmed: 26195750
Clin Cancer Res. 2019 Jan 1;25(1):266-276
pubmed: 30287549
J Neurooncol. 2017 Jan;131(2):233-244
pubmed: 27770278
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
Biochem Biophys Res Commun. 2014 Aug 22;451(2):295-301
pubmed: 25086355
J Extracell Vesicles. 2019 Aug 27;8(1):1656993
pubmed: 31497265
J Neurooncol. 2015 Jun;123(2):205-16
pubmed: 25903655
Nat Commun. 2011 Feb 01;2:180
pubmed: 21285958
Nature. 2019 Jan;565(7741):654-658
pubmed: 30675060
PLoS One. 2016 Sep 29;11(9):e0163665
pubmed: 27684368
Neuro Oncol. 2019 May 6;21(5):606-615
pubmed: 30561734
Sci Adv. 2018 Mar 07;4(3):eaar2766
pubmed: 29532035
Sci Adv. 2019 Nov 20;5(11):eaax8849
pubmed: 31799396
Neuro Oncol. 2017 Oct 19;19(11):1494-1502
pubmed: 28453784